Pulmonology
Hello, Suzanne Dixon
Manage E-mail  |  Logout

Article ID

Home
General Pulmonology
Messages (38)
Conferences
Jobs
Newsletters
My Library
Topics in
Pulmonology
        Apnea/Sleep Disorders
        Asthma/Atopy
        Basic Science/Genetics
        COPD
        CV/Thromboembolic
        Clinical Pharmacology
        Critical Care
        Cystic Fibrosis
        Diagnostic/Lung Function
        Economics of Medicine
        Lung/Thoracic Oncology
        Occupational Health
        Pediatric Pulmonology
        Popular Press
        Pulm/Thoracic Infections
        Restrictive Lung Dz
        Sarcoidosis
        Surgery/Trauma
        Transplantation
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

Need hemophilia CME? Here’s the latest, straight from ISTH 2009 in Boston, with expert commentary on the topics you...
Victoria Luken, MDLinx CME
FDA Update: Bevacizumab + Interferon Alfa Approved for Renal Cell Carcinoma
Tracy Hampton, PhD, MDLinx Oncology
Congress Proposes SGR Fix
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all

Articles: Clinical Pharmacology



Latest (3) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases
Journal of Clinical Oncology, 09/11/09
Sponsor
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer
Journal of Clinical Oncology, 09/11/09
Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension
Anti-Cancer Drugs, 09/11/09
Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non–small-cell lung cancer
Journal of Clinical Oncology, 09/10/09
Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis
Pharmacology & Therapeutics, 09/10/09
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
BMC Pulmonary Medicine, 09/10/09    Free full text
The Measurement of Time to First Antibiotic Dose for Pneumonia in the Emergency Department: A White Paper and Position Statement Prepared for the American Academy of Emergency Medicine
The Journal of Emergency Medicine, 09/10/09
Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: Systematic review with meta-analysis
Respiratory Medicine, 09/09/09
Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells
International Journal of Cancer, 09/08/09
Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial
European Respiratory Journal, 09/08/09
Comparative in vitro performance of valved holding chambers with a budesonide/formoterol pressurized metered-dose inhaler
Allergy and Asthma Proceedings, 09/08/09
Mortality in the 4 Year Trial of Tiotropium (UPLIFT) in Patients with COPD
American Journal of Respiratory and Critical Care Medicine, 09/04/09
Oral versus IV antibiotics for CAP in children: a cost minimisation analysis
European Respiratory Journal, 09/04/09
A phase II study of weekly docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer
Journal of Thoracic Oncology, 09/04/09
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 09/04/09
Evaluation of withdrawal of maintenance tiotropium in COPD
Respiratory Medicine, 09/04/09
Budesonide/formoterol Combination as a Maintenance and Rescue Therapy
Journal of Asthma, 09/04/09
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
Lung Cancer, 09/04/09
Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial
European Respiratory Journal, 09/03/09
IFCT-0401 trial: A phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype
Journal of Thoracic Oncology, 09/03/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more...
250 Available Pages
First    Prev    9      10      11      12      13      14      15      16      17      18      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.